Coronavirus and other respiratory virus outbreaks not found in blood
March 24, 2020

More than 100 businesses and schools have canceled blood drives across South Texas due to the coronavirus outbreak. 

With these countless loss of donations, the blood supply here and across the nation is in emergency mode.

With this amount of uncertainty, it’s understandable why donors ask the South Texas Blood & Tissue Center if coronavirus can be carried in blood.

“People are not at risk for contracting coronavirus, either by giving blood or receiving a blood transfusion, and we’re taking every precaution to ensure our donor rooms and bloodmobiles are a healthy environment,” says Dr. Samantha Gomez Ngamsuntikul, associate medical director at STBTC.

March 2, 2020

The Food and Drug Administration has issued a draft of changes to the blood donor questionnaire that potentially could increase the number of eligible donors in South Texas.

Currently, anyone who received treatment with human growth hormone or bovine insulin for diabetes cannot donate blood. Those restrictions could be eliminated under the proposal.

Dr. Samantha Gomez Ngamsuntikul, Associate Medical Director at BioBridge Global, said the change could increase the number of eligible donors, though the size of the increase was difficult to estimate.

“Donors previously deferred for time spent on a military base may be eligible for reentry (to the list of eligible donors),” she said. “Donors previously deferred for bovine insulin are also potentially eligible for reentry.”

February 24, 2020


Kenneth Bertram, MD, PhD, FACP is the former commander of the Walter Reed Army Institute of Research, and Principal Assistant for Acquisition for the U.S. Army Medical Research and Materiel Command. He joined the BioBridge Global Regenerative Medicine Advisory Board in 2018.

In a question-and-answer session, he talked about the future of regenerative medicine, BioBridge Global’s potential in the field and how he developed an interest in regenerative medicine:

How do you think regenerative medicine fits into the future of medical care?

February 13, 2020

Members of The Blood & Tissue Center Foundation board of directors got a look at the future of healthcare at their first meeting of 2020.


Becky Cap, Chief Operating Officer of GenCure, addresses members of The Blood & Tissue Center Foundation board of directors at their first meeting of 2020.

The board met at the GenCure Biomanufacturing facility, which is part of the VelocityTX bioscience hub on San Antonio’s East Side. After the formal meeting, board members took one of the first tours of the facility, which is scheduled to open this spring.

February 10, 2020

Five interns from the University of Texas Rio Grande Valley made a difference in South Texas.

During their time at BioBridge Global, they helped organize paperwork for Center for Apheresis and Therapeutic Services (CATS), assembled birth tissue kits for the Cord Blood and Birth Tissue team, and gave feedback on using social media to encourage the younger generation to donate blood or stem cells.